PathogenDx, Inc., an innovator in DNA-based pathogen testing technology for the cannabis, hemp, agriculture and food safety industries, today announced $7.5 million in Series B funding. This latest investment round was led by Cresco Capital Partners with participation from Altitude Investment Management, Arcadian Investment Partners, Panther Opportunity Fund LLC, Salveo … [Read more...] about DNA-based pathogen testing company PathogenDx Announces $7.5 Million in Series B Funding